Control of Bacterial Growth l Antibiotics / Chemotherapy –History –Properties –Testing –Spectrum of Antimicrobial Action –Modes of Action –Survey of Drugs.

Post on 27-Dec-2015

213 Views

Category:

Documents

1 Downloads

Preview:

Click to see full reader

Transcript

Control of Bacterial Control of Bacterial GrowthGrowth Antibiotics / Chemotherapy

– History– Properties– Testing– Spectrum of Antimicrobial Action– Modes of Action– Survey of Drugs

Antibiotics Antibiotics

History– Quinine for malaria– Willow bark for treating fever– Paul Ehrlich - staining of bacteria led

to ideas for chemotherapy– Fleming (1928) observed the effect of

Penicillium of on Staphylococcus– Flory & Chain (1940) developed

penicillin and clinically tested it

AntibioticsAntibiotics Peruvian Indians - treat fevers and reduce shivering with

cinchona bark Use " Peruvian bark" was first recorded by the Jesuits in

1633 Countess Anna del Chinchón. was cured of the ague (a

name for malaria the time) in 1638 The Dutch bought the Bolivian seeds from Charles Ledger,

a British botanist, planted them in Java, and came to monopolize the world's supply of quinine for close to 100 years.

A formal chemical synthesis was accomplished in 1944 by American chemists Woodward and W.E. Doering

Since then, several more efficient quinine syntheses have been achieved, but none of them can compete in economic terms with isolation of the alkaloid from natural sources.

Malaria resistant to synthetic but less so to natural The first synthetic organic dye, mauveine, was discovered

by William Henry Perkin in 1856 while he was attempting to synthesize quinine.

AntibioticsAntibiotics 1928 – Fleming discovers penicillin and

isolates a crude form of the chemical 1930’s - Florey and Chain further refine

chemical methods for isolation of penicillin from culture filtrates

WWII – work transferred to Peoria IL – development of submerged culture processes

Post WWII – additional markets for penicillin leads to resistance

AntibioticsAntibiotics

Properties– Selective toxicity (e.g. sulfanilamide

mimics PABA in folic acid synthesis)– Sources

»Microorganisms»Synthetic agents»Plants

AntibioticsAntibiotics

Testing– Broth dilution– Agar dilution– Disc diffusion

AntibioticsAntibiotics

Broth dilution – MIC - minimal inhibitory concentration

» smallest concentration that stops growth» Successive dilutions inoculated with same

number bacteria» Turbidity measure when compared to control

(could also do dilutions & plate counts)

– MBC - minimal bactericidal concentration» Concentration of antibiotic where cell number is

reduced significantly» Will typically be a higher concentration than MIC

AntibioticsAntibiotics

Agar dilution– Dilute drug into agar at varying

concentrations– Can test multiple species of bacteria– Not very quantitative

AntibioticsAntibiotics

Disc-Diffusion– Discs with known

concentrations of antibiotics seeded onto “lawn” of bacteria

– Zone of clearing around disk a measure of effectiveness of antibiotic

AntibioticsAntibiotics

Spectrum of Antimicrobial Activity– Selectively toxic drugs; uses

differences between prokaryotic and eukaryotic cells

– Broad spectrum – affect both G+ and G-

– Antibiotic effect, e.g. penicillin and Candida albicans

AntibioticsAntibiotics

Modes of Action– Bactericidal vs. Bacteriostatic– Cell Wall– Protein Synthesis– Plasma membrane– Nucleic Acid Synthesis– Essential Metabolites

AntibioticsAntibiotics

Bactericidal vs. Bacteriostatic– Bactericidal - kills– Bacteriostatic - inhibits growth but

once removed growth can resume

AntibioticsAntibiotics

Inhibition of Cell Wall Synthesis– Uniqueness of bacterial cell wall– Prevent peptidoglycan synthesis or

peptide cross-linking from forming– Penicillins & cephalosporins

AntibioticsAntibiotics

Inhibition of Protein Synthesis– Bacterial protein synthesis

significantly different than eukaryotic e.g. 70S vs. 80S ribosome or elongation & termination factors

– Amyloglycosides (streptomycin and gentamicin)

AntibioticsAntibiotics

Injury of Plasma Membrane– Alteration in permeability– Interference with required

consituents, e.g. sterols in fungal lipid membranes

– Polymixin B (bacteria)– Amphotericin B or miconazole

(fungal)

AntibioticsAntibiotics

Essential Metabolites– Para-aminobenzoic acid is an

essential cofactor used by bacteria to synthesize folic acid (a vitamin that functions as a coenzyme in the synthesis of nucleic acid precursors)

– animals ingest folic acid– Sulfanilamide is an analog of PABA

AntibioticsAntibiotics

Inhibition of Nucleic Acid Synthesis– Nucleic acid synthesis especially

mRNA and DNA– Rifampin and quinolones– Limited utility because of RNA’s and

DNA’s essential role in both prokaryotic and eukaryotic cells

AntibioticsAntibiotics

Survey of Drugs - Cell Wall Synthesis– Penicillins (G, V)– Semisynthetic penicillins (Ampicillin)– Monobactams– Vancomycin - Glycopeptide topical– Cephalosporins– Bacitracin - bacterial origin; topical use– Isoniazid - tuberculosis– Ethambutol - tuberculosis

AntibioticsAntibiotics

Survey of Drugs - Protein Synthesis– Amyloglycosides (Streptomycin,

neomycin Gentamicin)– Tetracyclines - Bacteriostatic– Chloramphenicol – Macrolides - Erythromycin -

Bacteriostatic

AntibioticsAntibiotics

Survey of Drugs - Plasma Membrane– Polymyxin B - topical; works against

G-

AntibioticsAntibiotics

Survey of Drugs - Nucleic Acids– Rifampin– Quinolones– Fluorquinolones

AntibioticsAntibiotics

Survey of Drugs - Essential Metabolites– Sulfonamides

top related